-
Bridge Biotherapeutics readies third IPO try after clinching mega dealIndustryAug 1, 2019‘No research, development only’ company proves potential through W1.5tr license-out deal with Boehringer Ingelheim -
Avellino Labs aims to set example for Kosdaq listing of US firmsIndustryJun 30, 2019From assisting disease prevention with DNA diagnosis, company aims for potentially curing genetic diseases
MOST POPULAR
-
01Fashion brand Badblood under fire for ‘blackfishing’ on Instagram
-
‘Korea’s solar push might end up helping China’02
-
03S. Korea retains position as 7th largest exporter in 2020
-
Confirmed cases remain in mid-300s; around 21,000 vaccinated04
-
05Boys no longer preferred
-
Can international court resolve ‘comfort women’ issue?06
-
07New cases below 400; virus curbs extended for 2 weeks
-
New virus cases in 300s for 2nd day, cluster infections still worrisome08
-
09[Newsmaker] Child abuse can now lead to death penalty in South Korea
-
Hyundai Motor says sales of IONIQ 5 in Europe show solid start10